Comparison of standard versus low-dose valganciclovir regimens for cytomegalovirus prophylaxis in high-risk liver transplant recipients [0.03%]
高风险肝移植受者更适于接受标准剂量还是低剂量缬加昔洛韦预防巨细胞病毒感染？一项系统综述和meta分析
Alexandra L Bixby,Linda Fitzgerald,Jeong M Park et al.
Alexandra L Bixby et al.
Purpose: The purpose of this study was to compare the safety and efficacy of two valganciclovir (VGCV) institutional dosing protocols for cytomegalovirus (CMV) prophylaxis in liver transplant (LT) recipients with CMV sero...
Effect of glecaprevir/pibrentasvir on weight-adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients [0.03%]
glecaprevir/pibrentasvir对心脏和肾脏移植受者校正体重的他克莫司谷/剂量比的影响
Daryl U Nnani,Alesa Campbell,Maria Ajaimy et al.
Daryl U Nnani et al.
Objective: The pharmacokinetic implications of direct-acting antiviral (DAA) use on tacrolimus posttransplant are unknown. This study sought to investigate the effects of glecaprevir/pibrentasvir (G/P), a CYP3A4 substrate...
Rujittika Mungmunpuntipantip,Viroj Wiwanitkit
Rujittika Mungmunpuntipantip
Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients [0.03%]
评估泛昔洛韦小剂量用于CMV低风险器官移植受者HSV和VZV的预防效力
Ashley Crouch,Mariesa Le,Christin Rogers et al.
Ashley Crouch et al.
Objective: Famciclovir is a recommended option for herpes simplex virus (HSV) and varicella-zoster virus (VZV) prophylaxis in cytomegalovirus (CMV) low-risk solid organ transplant (SOT) recipients in current guidelines; h...
A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient [0.03%]
一例mRNA-1273新冠疫苗(Moderna)完全接种者发生的严重新冠肺炎：病例报告(英文版)
Kai-Ming Chang,Ilan Berlinrut,Frances R Wallach
Kai-Ming Chang
The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country [0.03%]
异烟肼对高结核病负担国家肾移植受者的预防效果
Sunil Kumar Dodani,Asma Nasim,Tahir Aziz et al.
Sunil Kumar Dodani et al.
Introduction: Renal transplant recipients are at high risk of tuberculosis (TB). We started isoniazid (INH) prophylaxis of 1 year duration in all renal transplant recipients from April 2009. Our aim was to assess the inci...
Fatal recurrent disseminated Lomentospora prolificans infection during autologous hematopoietic stem cell transplantation: A case report and review, and discussion on the importance of prolonged neutropenia [0.03%]
中性粒细胞减少症持续期间自体造血干细胞移植患者并发致死的复发播散性Lomentospora prolificans感染：病例报告、文献回顾及讨论
Vanessa J Gow-Lee,Justin T Moyers,Daniel K Rogstad
Vanessa J Gow-Lee
Infections with Scedosporium and Lomentospora species, in particular Lomentospora (previously Scedosporium) prolificans, are nearly universally fatal and rapidly-progressive in the transplant population. We report a case of a patient with d...
Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated [0.03%]
COVID-19受体器官移植患者的免疫抑制：数据有所增加，但仍很复杂
Madeleine R Heldman,Olivia S Kates,Cynthia E Fisher et al.
Madeleine R Heldman et al.
"Outcomes of COVID-19 in solid organ transplant (SOT) recipients: a matched cohort study" by Pereira et al found similar 28 day mortality among hospitalized SOT recipients and comorbidity matched controls, shedding light on the relationship...
Q fever presenting with hepatic and splenic lesions in a kidney transplant recipient [0.03%]
一名肾移植受者出现肝脾病变的 Q 热病例报告
Bonnie Ann Sarrell,John Laurenzano,Jared Freitas et al.
Bonnie Ann Sarrell et al.
Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry [0.03%]
2005至2019年法国肾移植受者的孢子虫病的流行病学和临床研究：TRANS-SPORE登记系统
Clément Dumond,Florence Aulagnon,Isabelle Etienne et al.
Clément Dumond et al.
Introduction: Microsporidiosis is an emerging opportunistic infection in renal transplantation (RT) recipients. We aimed to describe its clinical presentation and treatment. ...